JP2016517691A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2016517691A5 JP2016517691A5 JP2016511126A JP2016511126A JP2016517691A5 JP 2016517691 A5 JP2016517691 A5 JP 2016517691A5 JP 2016511126 A JP2016511126 A JP 2016511126A JP 2016511126 A JP2016511126 A JP 2016511126A JP 2016517691 A5 JP2016517691 A5 JP 2016517691A5
- Authority
- JP
- Japan
- Prior art keywords
- chinese hamster
- sequence
- target polypeptide
- expression cassette
- hamster ovary
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB201308017A GB201308017D0 (en) | 2013-05-03 | 2013-05-03 | Expression process |
| GB1308017.1 | 2013-05-03 | ||
| GB1320339.3 | 2013-11-18 | ||
| GB201320339A GB201320339D0 (en) | 2013-11-18 | 2013-11-18 | Expression Process |
| PCT/GB2014/000165 WO2014177826A1 (en) | 2013-05-03 | 2014-04-29 | Expression process |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2016517691A JP2016517691A (ja) | 2016-06-20 |
| JP2016517691A5 true JP2016517691A5 (enExample) | 2017-06-08 |
| JP6545153B2 JP6545153B2 (ja) | 2019-07-17 |
Family
ID=50639794
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016511126A Active JP6545153B2 (ja) | 2013-05-03 | 2014-04-29 | 発現方法 |
Country Status (12)
| Country | Link |
|---|---|
| US (3) | US9873891B2 (enExample) |
| EP (1) | EP2992104B1 (enExample) |
| JP (1) | JP6545153B2 (enExample) |
| KR (1) | KR102180660B1 (enExample) |
| CN (2) | CN114395584B (enExample) |
| BR (1) | BR112015027373A2 (enExample) |
| CA (1) | CA2910877C (enExample) |
| DK (1) | DK2992104T3 (enExample) |
| ES (1) | ES2732907T3 (enExample) |
| RU (1) | RU2731717C2 (enExample) |
| SG (1) | SG11201508447TA (enExample) |
| WO (1) | WO2014177826A1 (enExample) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3323826A1 (en) * | 2016-11-21 | 2018-05-23 | Danmarks Tekniske Universitet | Native chinese hamster ovary cell secretion signal peptides for production of recombinant polypeptides |
| JP7032438B2 (ja) | 2017-12-11 | 2022-03-08 | 富士フイルム株式会社 | 動物細胞、動物細胞の製造方法および目的タンパク質の製造方法 |
| WO2020122049A1 (ja) | 2018-12-11 | 2020-06-18 | 富士フイルム株式会社 | 動物細胞、動物細胞の製造方法および目的タンパク質の製造方法 |
| CN109837277A (zh) * | 2019-03-01 | 2019-06-04 | 深圳生生凡非基因技术有限公司 | 一种cpgk嵌合型启动子、腺相关病毒载体及其应用 |
| JP7352650B2 (ja) | 2019-11-29 | 2023-09-28 | 富士フイルム株式会社 | 細胞培養方法、抗体製造方法、有機酸除去方法、及び、抗体 |
| EP4276167A1 (en) | 2021-01-07 | 2023-11-15 | FUJIFILM Corporation | Cell selection method, device and device system |
| WO2022196710A1 (ja) | 2021-03-17 | 2022-09-22 | 富士フイルム株式会社 | 細胞培養方法、及び有用物質の製造方法 |
| CN112980852B (zh) * | 2021-05-18 | 2021-08-13 | 北京华芢生物技术有限公司 | 新型冠状病毒b.1.351南非突变株rbd的基因及其应用 |
| WO2022249089A1 (en) | 2021-05-27 | 2022-12-01 | Janssen Biotech, Inc. | Compositions and methods for the treatment of prostate cancer |
| EP4410957A4 (en) | 2021-09-30 | 2026-01-28 | Fujifilm Corp | CELL CULTURE PROCESS AND PROCESS FOR PRODUCING USEFUL SUBSTANCE |
| EP4450609A1 (en) | 2021-12-15 | 2024-10-23 | FUJIFILM Corporation | Method for producing product, and cell culture apparatus |
| CN118974267A (zh) | 2022-03-28 | 2024-11-15 | 富士胶片株式会社 | 产物的生产方法及产物 |
| CN118974268A (zh) | 2022-03-31 | 2024-11-15 | 富士胶片株式会社 | 产物的制造方法及产物 |
| KR20250022761A (ko) * | 2022-06-10 | 2025-02-17 | 후지필름 다이오신쓰 바이오테크놀로지스 유케 리미티드 | 세포의 작출 방법, 헤테로 다량체 단백질의 제조 방법, 바이스페시픽 항체의 제조 방법, 벡터 세트, 포유동물 세포, cho 세포, 및 세포 풀의 작출 방법 |
| WO2024071373A1 (ja) | 2022-09-29 | 2024-04-04 | 富士フイルム株式会社 | 生産物の製造方法 |
| JPWO2024248120A1 (enExample) | 2023-05-31 | 2024-12-05 | ||
| WO2024248118A1 (ja) | 2023-05-31 | 2024-12-05 | 富士フイルム株式会社 | 細胞培養方法および生産物の製造方法 |
| CN121175432A (zh) | 2023-05-31 | 2025-12-19 | 富士胶片株式会社 | 生产物的生产方法 |
| WO2025244971A1 (en) | 2024-05-20 | 2025-11-27 | Janssen Biotech, Inc. | Compositions and methods for the treatment of prostate cancer |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2003093295A2 (en) * | 2002-04-30 | 2003-11-13 | University Of North Carolina At Chapel Hill | Secretion signal vectors |
| US7186699B2 (en) * | 2003-06-03 | 2007-03-06 | Cell Genesys, Inc. | Method for treating cancer by vector-mediated delivery of one or more anti-angiogenic or pro-apoptotic genes |
| US8029783B2 (en) * | 2005-02-02 | 2011-10-04 | Genentech, Inc. | DR5 antibodies and articles of manufacture containing same |
| EP1739179A1 (en) * | 2005-06-30 | 2007-01-03 | Octapharma AG | Serum-free stable transfection and production of recombinant human proteins in human cell lines |
| GB0602173D0 (en) * | 2006-02-03 | 2006-03-15 | Avecia Ltd | Expression system |
| DK2115151T3 (en) * | 2006-12-28 | 2015-01-05 | Janssen Biotech Inc | PROCESSES AND VECTORS FOR GENERATING ASIALYLEREDE immunoglobulins |
| KR101618767B1 (ko) * | 2008-09-02 | 2016-05-09 | 한국생명공학연구원 | 외래단백질을 고효율로 생산하는 리더서열 |
| EP2370469B1 (en) * | 2008-12-31 | 2018-09-05 | Bharat Serums And Vaccines Ltd. | Anti-rhd monoclonal antibodies |
| SG173705A1 (en) | 2009-03-05 | 2011-09-29 | Abbott Lab | Il-17 binding proteins |
| GB0905331D0 (en) * | 2009-03-27 | 2009-05-13 | Avecia Biolog Ltd | Expression process |
| KR101420274B1 (ko) * | 2011-06-13 | 2014-07-21 | 주식회사 종근당 | Ｃｓｐ－ｂ ５＇ｓａｒ 인자를 포함하는 동물세포 발현 벡터 및 이를 이용한 재조합 단백질의 제조방법 |
-
2014
- 2014-04-29 KR KR1020157032562A patent/KR102180660B1/ko active Active
- 2014-04-29 CA CA2910877A patent/CA2910877C/en active Active
- 2014-04-29 BR BR112015027373A patent/BR112015027373A2/pt not_active Application Discontinuation
- 2014-04-29 SG SG11201508447TA patent/SG11201508447TA/en unknown
- 2014-04-29 WO PCT/GB2014/000165 patent/WO2014177826A1/en not_active Ceased
- 2014-04-29 JP JP2016511126A patent/JP6545153B2/ja active Active
- 2014-04-29 CN CN202111508425.XA patent/CN114395584B/zh active Active
- 2014-04-29 ES ES14721474T patent/ES2732907T3/es active Active
- 2014-04-29 US US14/787,669 patent/US9873891B2/en active Active
- 2014-04-29 EP EP14721474.6A patent/EP2992104B1/en active Active
- 2014-04-29 CN CN201480024993.4A patent/CN105392889A/zh active Pending
- 2014-04-29 RU RU2015151626A patent/RU2731717C2/ru active
- 2014-04-29 DK DK14721474.6T patent/DK2992104T3/da active
-
2017
- 2017-12-12 US US15/838,868 patent/US11306323B2/en active Active
-
2022
- 2022-03-15 US US17/694,760 patent/US20220213500A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2016517691A5 (enExample) | ||
| RU2015151626A (ru) | Способ экспрессии | |
| PH12020551039A1 (en) | Non-viral dna vectors and uses thereof for antibody and fusion protein production | |
| HK1207575A1 (en) | Bispecific asymmetric heterodimers comprising anti-cd3 constructs | |
| EA202092093A1 (ru) | Композиции и способы перепрограммирования tcr с применением слитых белков | |
| IL309975B1 (en) | Anti-c5 antibodies and uses thereof | |
| HRP20201153T1 (hr) | Pd-1 sredstva visokog afiniteta i načini uporabe | |
| JP2015529826A5 (enExample) | ||
| EA202090931A3 (ru) | Композиции и способы перепрограммирования tcr с помощью гибридных белков | |
| HRP20191865T1 (hr) | Novi heterodimerni proteini | |
| WO2016100241A3 (en) | Methods for controlled activation or elimination of therapeutic cells | |
| BR112012018914A2 (pt) | "anticorpo humanizado, proteína de ligação de antígeno, molécula de ácido nucleico, vetor de expressão, célula hospedeira recombinante, proteína de ligação de anticorpo ou de antígeno, métodos para a produção de uma proteína de ligação de antígeno e para tratar um sujeito afetado por uma doença autoimune ou inflamatória, e, composição farmacêutica." | |
| BR112017005245A2 (pt) | animal não humano geneticamente modificado, métodos para produzir célula t, hibridoma de célula t, um ácido nucleico, um anticorpo específico, uma célula humana, um animal não humano geneticamente modificado e para induzir uma resposta imunológica, célula, hibridoma de célula t, ácido nucleico, anticorpo específico, receptor de antígeno quimérico, embrião não humano, locus de um receptor de antígeno quimérico, e, composição de ácidos nucleicos. | |
| JP2014110814A5 (enExample) | ||
| JP2015519055A5 (enExample) | ||
| HK1243333A1 (zh) | 用於修饰的t细胞的方法和组合物 | |
| AR063683A1 (es) | Anticuerpos para il-17a | |
| RU2014118869A (ru) | Мыши с ограниченной тяжелой цепью иммуноглобулина | |
| MY172718A (en) | Humanized universal light chain mice | |
| BRPI0812091A2 (pt) | Método para fabricar uma proteína policlonal recombinante | |
| MX376623B (es) | Cultivo celular metabolicamente optimizado. | |
| HRP20201633T1 (hr) | Protutijela koja se vežu na il-23 | |
| WO2013039996A4 (en) | Compositions and methods for brown fat induction and activity using fndc5 | |
| RU2016136855A (ru) | Биомаркер-направленная многоцелевая иммунотерапия | |
| JP2013539369A5 (enExample) |